Protein substitutes (PS) are an essential component in the dietary management of phenylketonuria (PKU). PS are available as phenylalanine-free amino-acid mixtures (AAM), glycomacropeptide-based PS ...

Argentina has documented over 1,200 cases of inborn metabolic disorders annually, with phenylketonuria being the most ...

GENEVA, SWITZERLAND / ACCESSWIRE / October 4, 2024 /RELIEF THERAPEUTICS (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the ...

NGGT Inc., ("Next Generation Gene Therapeutics" or "NGGT"), a clinical-stage biotechnology company pioneering the next wave of gene therapy innovation for genetic rare diseases, today announced ...

Considering taking supplements to treat phenylketonuria pku? Below is a list of common natural remedies used to treat or reduce the symptoms of phenylketonuria pku. Follow the links to read common ...

While questions remain about whether aspartame is linked to cancer, the sweetener should be avoided by anyone with ...

You might be more familiar with the term 'heel prick test' as it was formerly known, but the 'newborn blood spot test' is ...

Group 2 encompasses diseases that need long-term or lifelong management but have relatively lower treatment costs, such as ...

For the three months ended September 30, 2024, Synlogic reported a consolidated net loss of $ (0.1) million, or ($0.01) per share, compared to a consolidated net loss of $ (12.1) million, or $ (2.57) ...

BioMarin posts Q3 EPS of $0.91, nearly doubling last year's $0.46 and topping estimates. Sales rose 28%, driven by strong ...

It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J.

The restructuring and other charges were a result of the Company's decision in February 2024 to discontinue Synpheny-3, its pivotal study of labafenogene marselecobac (SYNB1934) in phenylketonuria ...